Clinical Trials Browser

Phase 2 × Ganglioneuroblastoma × Stem Cell Transplantation × Clear all

NCT03786783 2025-10-09

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Phase 2 Active not recruiting

42 enrolled 12 charts

Ganglioneuroblastoma